Molecular Pharmacology (USA), Ltd. (MLPH)

Market Cap	9.70M +922.5%
Revenue (ttm)	n/a
Net Income	-105.18K
EPS	-0.00
Shares Out	999.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,500
Average Volume	118,097
Open	0.0097
Previous Close	0.0005
Day's Range	0.0097 - 0.0097
52-Week Range	0.0000 - 0.0097
Beta	-4.36
RSI	79.48
Earnings Date	n/a

About MLPH

Molecular Pharmacology (USA), Ltd., a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical di...

• Industry: Shell Companies
• Sector: Financials
• CEO: Jeffrey Edwards
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: MLPH